Tissue Regenix's market cap is currently £5.16M. The company's EPS TTM is p-0.00984483773; its P/E ratio is -4.90; Tissue Regenix is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
